PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate, and when can generic versions of Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate launch?

Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate is a drug marketed by Cent Pharms, Graham Dm, and Kv Pharm. and is included in four NDAs.

The generic ingredient in PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine hydrochloride profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE?
What are the global sales for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE?
What is Average Wholesale Price for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE?

Summary for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

US Patents:	0
Applicants:	3
NDAs:	4
Clinical Trials:	2
DailyMed Link:	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE at DailyMed

Drug patent expirations by year for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Recent Clinical Trials for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
GlaxoSmithKline	Phase 4
Sino-American Tianjin Smith Kline & French Laboratories Ltd	Phase 4
Magna Pharmaceuticals, Inc.	Phase 3

See all PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE clinical trials

US Patents and Regulatory Information for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Cent Pharms	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	019428-001	Aug 2, 1988		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Kv Pharm	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	071455-001	Mar 1, 1989		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Graham Dm	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	018844-001	Mar 20, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Graham Dm	PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE	chlorpheniramine maleate; pseudoephedrine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	018843-001	Mar 18, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

AI Research Assistant

Questions you can ask:

Summary for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Recent Clinical Trials for PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Make Better Decisions: Try a trial or see plans & pricing